Sunitinib malate
Tocris Bioscience | Catalog # 3768
Key Product Details
Description
Alternative Names
Product Description
Sunitinib malate is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor (Ki values are 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT respectively). Also inhibits cellular receptor phosphorylation of FLT3, RET and CSF-1R. Exhibits antiangiogenic and antitumor activity in multiple xenograft models.Licensing Information
Sold for research purposes under agreement from Pfizer Inc.
Product Specifications for Sunitinib malate
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 13.31 | 25 |
Preparing Stock Solutions for Sunitinib malate
The following data is based on the product molecular weight 532.56.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.25 mM | 7.51 mL | 37.55 mL | 75.11 mL |
| 1.25 mM | 1.50 mL | 7.51 mL | 15.02 mL |
| 2.5 mM | 0.75 mL | 3.76 mL | 7.51 mL |
| 12.5 mM | 0.15 mL | 0.75 mL | 1.50 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 11 publications citing the usage of this product.
- Roskoski Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem.Biophys.Res.Comm. 2007 PMID: 17367763
- O'Farrell SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood 2003 PMID: 12531805
- Faivre Molecular basis for suni. efficacy and future clinical development Nat.Rev.Drug Discov. 2007 PMID: 17690708
- Mendel In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin.Cancer Res. 2003 PMID: 12538485
Product Documents for Sunitinib malate
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Sunitinib malate
For research use only
Related Research Areas
Citations for Sunitinib malate
Customer Reviews for Sunitinib malate
There are currently no reviews for this product. Be the first to review Sunitinib malate and earn rewards!
Have you used Sunitinib malate?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review